Document is current
Any future updates will be listed below
-
Authors
Teh, Boon Lin https://orcid.org/0000-0001-5455-0233
Ong, Ariel Yuhan https://orcid.org/0000-0001-9300-573X
Mehta, Ankur
Hoang, Vy
Settle, Chris
Lotery, Andrew J. https://orcid.org/0000-0001-5541-4305
Charbel Issa, Peter https://orcid.org/0000-0002-0351-6673
Smith, Jonathan
Steel, David H. https://orcid.org/0000-0001-8734-3089
- License Information
-
More Information
Article History
Received: 27 August 2024
Revised: 16 January 2025
Accepted: 31 January 2025
First Online: 12 February 2025
Competing interests
: DHS has received consulting fees from Alcon, Gyroscope Therapeutics (a Novartis company), Alimera, Complement therapeutics, BVI, and Roche, and research funding from Alcon, Gyroscope Therapeutics, Boehringer Ingelheim, DORC, Roche, and Bayer – all unrelated to this project. The other authors declare that they have no conflict of interest.
